*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Clinical Study of Psoriasis and its Association With Metabolic Comorbidities

Author: ANJUMEENA. D, SUNDARAMORTHY SRINIVASAN
Abstract: Psoriasis is a chronic inflammatory disease connected with comorbidities such as dyslipidaemia, central obesity, hypertension and glucose intolerance. This study was done to assess the clinical and laboratory parameters associated with psoriasis.Patients diagnosed with psoriasis and those fulfilling the inclusion criteria were chosen. Conversantagreement was acquired from all the patients, history of duration of psoriasis, past history, family history and treatment history were noted down. Height and weight were unrushed and BMI was intended. Waist perimeter was unhurried. Blood pressure was recorded. The blood investigations and electrocardiogram were also taken.The total number of patients in my study was 106.Out of which 56.6% had association with metabolic syndrome and 30.2% had ECG abnormalities. Both genders were equally affected. Most of the patients (32%) were between the age group of 58 to 67 years. The duration of psoriasis ranged from 1 month to 15 years. The mean (± standard deviation) duration of psoriasis was 5.9 years (±3.8 years) Psoriasis vulgaris was the most common type 81.1% out of which severe psoriasis was seen in most of the patients (39.6%).Nail changes were seen in 49.1%. Rendering to NCEP ATP III criteria, metabolic syndrome was present in more than half of the patients (56.6%). The individual metabolic comorbidities such as blood sugar and cholesterol levels augmented with the harshness of psoriasis. Hence patients with psoriasis are at augmented risk of emerging metabolic abnormalities and thereby leading to adverse cardiac outcomes. Hence patients with psoriasis should be routinely separated for the attendance of comorbidities as part of routine medical care.
Keyword: Psoriasis vulgaris,Electrocardiogram,Albumin,dyslipidaemia, central obesity, hypertension and glucose intolerance
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free